Injectable long-acting contraceptives.
Kaunitz
A M
AM
University of Florida Health Science Center-Jacksonville, Jacksonville, Florida, USA.
D000339:Affect / Q000187:drug effects; D015519:Bone Density / Q000187:drug effects; D002626:Chemistry, Pharmaceutical; D003271:Contraceptive Agents, Female / Q000737:chemistry / Q000494:pharmacology / Q000600:supply & distribution; D000075202:Contraindications; D003692:Delayed-Action Preparations; D004958:Estradiol / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology / Q000600:supply & distribution; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D017258:Medroxyprogesterone Acetate / Q000737:chemistry / Q000494:pharmacology / Q000600:supply & distribution; D010353:Patient Education as Topic; D018579:Patient Selection; D017891:Pharmacoepidemiology; D012307:Risk Factors; D014481:United States; D014486:United States Food and Drug Administration; D015430:Weight Gain / Q000187:drug effects
D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; C403500:Lunelle; D004958:Estradiol; D017258:Medroxyprogesterone Acetate